Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1
Authors:
- 1 December 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 865, 172745
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research Projects of Hunan Health Commission
This publication has 52 references indexed in Scilit:
- Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivoOncology Letters, 2013
- Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck CancerPLOS ONE, 2013
- Histone deacetylase inhibitor induction of epithelial–mesenchymal transitions via up-regulation of Snail facilitates cancer progressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Mechanism of Growth Inhibition of Prostate Cancer Xenografts by Valproic AcidJournal of Biomedicine and Biotechnology, 2012
- Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer CellsPLOS ONE, 2012
- Studies Using an in Vitro Model Show Evidence of Involvement of Epithelial-Mesenchymal Transition of Human Endometrial Epithelial Cells in Human Embryo ImplantationJournal of Biological Chemistry, 2012
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transitionMolecular Biology of the Cell, 2011
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatmentSeminars in Cancer Biology, 2009
- The role of histone deacetylases (HDACs) in human cancerMolecular Oncology, 2007